2025-01-01 2025-12-31 2025-12-31 false 15173879 Nextwell Diagnostics Limited 72110Research and experimental development on biotechnology iso4217:GBP xbrli:pure 151738792025-01-01 151738792025-12-31 151738792025-01-01 2025-12-31 15173879bus:Micro-entities2025-01-01 2025-12-31 15173879bus:AuditExempt-NoAccountantsReport2025-01-01 2025-12-31 15173879bus:FullAccounts2025-01-01 2025-12-31 15173879core:WithinOneYear2025-12-31 15173879core:AfterOneYear2025-12-31 15173879core:WithinOneYear2025-01-01 2025-12-31 15173879core:AfterOneYear2025-01-01 2025-12-31 15173879core:CurrentFinancialInstruments2025-12-31 15173879core:Non-currentFinancialInstruments2025-12-31 15173879core:CurrentFinancialInstruments2025-01-01 2025-12-31 15173879core:Non-currentFinancialInstruments2025-01-01 2025-12-31 15173879core:LandBuildings2025-01-01 2025-12-31 15173879core:FurnitureFittings2025-01-01 2025-12-31 15173879core:OfficeEquipment2025-01-01 2025-12-31 15173879core:Vehicles2025-01-01 2025-12-31 15173879core:PlantMachinery2025-01-01 2025-12-31 15173879core:OtherPropertyPlantEquipment2025-01-01 2025-12-31 15173879core:LandBuildings2025-12-31 15173879core:PlantMachinery2025-12-31 15173879core:Vehicles2025-12-31 15173879core:FurnitureFittings2025-12-31 15173879core:OfficeEquipment2025-12-31 15173879core:OtherPropertyPlantEquipment2025-12-31 15173879core:Right-of-useAssets2025-01-01 2025-12-31 15173879core:Right-of-useAssets2025-12-31 15173879core:Goodwill2025-01-01 2025-12-31 15173879core:PatentsTrademarksLicencesConcessionsSimilar2025-01-01 2025-12-31 15173879core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-01-01 2025-12-31 15173879core:OtherResidualIntangibleAssets2025-01-01 2025-12-31 15173879core:Goodwill2025-12-31 15173879core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-12-31 15173879core:PatentsTrademarksLicencesConcessionsSimilar2025-12-31 15173879core:OtherResidualIntangibleAssets2025-12-31 15173879dpl:CostSales2025-01-01 2025-12-31 15173879dpl:AdministrativeExpenses2025-01-01 2025-12-31 15173879dpl:DistributionCosts2025-01-01 2025-12-31151738792023-09-29 151738792024-12-31 151738792023-09-29 2024-12-31 15173879core:WithinOneYear2024-12-31 15173879core:AfterOneYear2024-12-31 15173879core:CurrentFinancialInstruments2024-12-31 15173879core:Non-currentFinancialInstruments2024-12-31 15173879core:LandBuildings2024-12-31 15173879core:PlantMachinery2024-12-31 15173879core:Vehicles2024-12-31 15173879core:FurnitureFittings2024-12-31 15173879core:OfficeEquipment2024-12-31 15173879core:OtherPropertyPlantEquipment2024-12-31 15173879core:Right-of-useAssets2024-12-31 15173879core:Goodwill2024-12-31 15173879core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-12-31 15173879core:PatentsTrademarksLicencesConcessionsSimilar2024-12-31 15173879core:OtherResidualIntangibleAssets2024-12-31 15173879dpl:AdministrativeExpenses2023-09-29 2024-12-3115173879bus:Director12025-01-01 2025-12-3115173879bus:PrivateLimitedCompanyLtd2025-01-01 2025-12-31
Nextwell Diagnostics Limited
Unaudited Financial Statements
for the year ended 31 December 2025
Company registration number 15173879
(England and Wales)

Company Information

For the year ended 31 December 2025
Director Creanga, Razvan

Registered office 16 Upper Woburn Place
London
WC1H 0AF

Registered number 15173879

Statement of Financial Position

As at 31 December 2025
2025
2024
£
£
£
£
Current assets
10,622
30,108
Creditors amounts falling due within one year
(166,189)
(152,650)
Net current assets (liabilities)
(155,567)
(122,542)
Total assets less current liabilities
(155,567)
(122,542)
Accruals and deferred income
-
(3,000)
Net assets (liabilities)
(155,567)
(125,542)
Capital and reserves
(155,567)
(125,542)

Notes to the Financial Statements

1. Employees

The average number of employees during the year was 0 (2024: 1).
The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the director on 7 September 2026 and are signed on its behalf by:

Creanga, Razvan
Creanga, Razvan
Director

Company registration number 15173879